Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial.
Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial.
复制标题
DOI：
10.1016/j.genhosppsych.2020.12.008
复制
发表时间：
2021-03
影响因子：
7
通讯作者：
Seng EB
中科院分区：
文献类型：
--
作者：
Minen MT;Corner S;Berk T;Levitan V;Friedman S;Adhikari S;Seng EB
尽管手部温度和肌电图生物反馈有预防偏头痛的证据，但迄今为止，还没有研究评估心率变异性 (HRV) 生物反馈对偏头痛的影响。 2 组随机试验将基于应用程序的 8 周 HRV 生物反馈 (HeartMath) 与候补名单对照进行比较。可行性/可接受性结果包括疗程的数量和持续时间、满意度、障碍和不良事件。主要临床结果是偏头痛特异性生活质量问卷 (MSQv2)。有 52 名参与者（每组 26 名）。平均而言，随机分配到 Hearthmath 组的参与者在停止之前完成了 29 个疗程（SD=29，范围：2-86），平均长度为 6:43 分钟，超过 36 天（SD=27，范围：0, 88）。 9/29 报告了技术障碍。 43% 的人表示他们可能会向其他人推荐 Heartmath。 Heartmath 对照和候补名单对照之间的平均 MSQv2 下降并不显着（估计 = 0.3，95% CI = -3.1 – 3.6）。 Heartmath 的高用户报告在第 30 天时 MSQv2 降低（−12.3 分，p=0.010），而低用户则没有（p=0.765）。对于偏头痛患者来说，基于应用程序的 HRV 生物反馈在有限的时间内是可行且可接受的。生物反馈和对照之间主要临床结果的变化没有差异；然而，该应用程序的高用户报告的好处比低用户更多。
Although hand temperature and electromyograph biofeedback have evidence for migraine prevention, to date, no study has evaluated heartrate variability (HRV) biofeedback for migraine. 2-arm randomized trial comparing an 8-week app-based HRV biofeedback (HeartMath) to waitlist control. Feasibility/acceptability outcomes included number and duration of sessions, satisfaction, barriers and adverse events. Primary clinical outcome was Migraine-Specific Quality of Life Questionnaire (MSQv2). There were 52 participants (26/arm). On average, participants randomized to the Hearthmath group completed 29 sessions (SD=29, range: 2–86) with an average length of 6:43 minutes over 36 days (SD=27, range: 0, 88) before discontinuing. 9/29 reported technology barriers. 43% said that they were likely to recommend Heartmath to others. Average MSQv2 decreases were not significant between the Heartmath and waitlist control (estimate = 0.3, 95% CI = −3.1 – 3.6). High users of Heartmath reported a reduction in MSQv2 at day 30 (−12.3 points, p=0.010) while low users did not (p=0.765). App-based HRV biofeedback was feasible and acceptable on a time-limited basis for people with migraine. Changes in the primary clinical outcome did not differ between biofeedback and control; however, high users of the app reported more benefit than low users.
登录
查看更多内容
影响因子：
5.9
作者：
HOLROYD, KA;PENZIEN, DB;CHILA, AG
通讯作者：
CHILA, AG
DOI：
10.1016/s1474-4422(17)30299-5
发表时间：
2017-11
期刊：
The Lancet. Neurology
影响因子：
--
作者：
GBD 2015 Neurological Disorders Collaborator Group
通讯作者：
GBD 2015 Neurological Disorders Collaborator Group
影响因子：
3.8
作者：
Lehrer PM;Gevirtz R
通讯作者：
Gevirtz R
影响因子：
9.9
作者：
Lipton, R. B.;Bigal, M. E.;Stewart, W. F.
通讯作者：
Stewart, W. F.
影响因子：
3.3
作者：
Andrasik, F.
通讯作者：
Andrasik, F.